Cervomed Inc. (CRVO)

Market is closed

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

News

Displaying 5

CervoMed Strengthens Leadership with Technical Operations Hire to Advance Neflamapimod Toward Phase 3

CervoMed Inc. (NASDAQ:CRVO) is one of the best-performing NASDAQ stocks according to analysts. On June 10, CervoMed announced a significant addition to its senior leadership team. Dr.

Keep Reading →

July 9th, 2025 - News

12 Best Performing NASDAQ Stocks According to Analysts

On July 3, Dan Ives, the Global Head of Tech Research at Wedbush, appeared on CNBC to suggest that AI will fuel a multi-year tech rally. Ives stated that he believes they are only at the beginning of...

Keep Reading →

July 8th, 2025 - Hedge Funds News

10 Best Short Squeeze Stocks to Buy According to Analysts

Stock market trading has an ever-changing environment. Short squeeze is among the few phenomena capable of capturing and holding the attention of such markets.

Keep Reading →

March 18th, 2025 - Hedge Funds Market Movers News

10 Best Short-Term Stocks To Buy Right Now

Thrilling highs, daunting lows, and the energized chase after the next big opportunity – this thoroughly defines the current stock market.

Keep Reading →

March 15th, 2025 - Hedge Funds Market Movers News

Why CervoMed (CRVO) Is Advancing Today

After meeting with CRVO's management and analyzing its recent drug trial results, Boral believes that the company can improve the performance of its neflamapimod drug by using a higher dose of 80 milligrams...

Keep Reading →

February 19th, 2025 - Market Movers News